Overview

Study in Women on the Effect of JNJ-64530440 on Oral Contraceptive and Midazolam, and the Effect of a High-fat Meal on JNJ-64530440

Status:
Withdrawn

Trial end date:
2021-11-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the effect of JNJ-64530440 single- and multiple-dose administration on the single-dose pharmacokinetics of drospirenone and ethinylestradiol (oral contraceptive) in healthy female participants.

Phase:

Phase 1

Details

Lead Sponsor:

Janssen Research & Development, LLC

Treatments:

Betadex
Contraceptive Agents
Contraceptives, Oral
Drospirenone
Drospirenone and ethinyl estradiol combination
Ethinyl Estradiol
Midazolam